Gary Bridger

12.5k total citations · 5 hit papers
118 papers, 10.0k citations indexed

About

Gary Bridger is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Gary Bridger has authored 118 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Immunology, 49 papers in Oncology and 38 papers in Hematology. Recurrent topics in Gary Bridger's work include Chemokine receptors and signaling (45 papers), HIV Research and Treatment (33 papers) and Hematopoietic Stem Cell Transplantation (31 papers). Gary Bridger is often cited by papers focused on Chemokine receptors and signaling (45 papers), HIV Research and Treatment (33 papers) and Hematopoietic Stem Cell Transplantation (31 papers). Gary Bridger collaborates with scholars based in United States, Belgium and United Kingdom. Gary Bridger's co-authors include Renato T. Skerlj, Dominique Schols, Geoffrey Henson, Gary Calandra, Erik De Clercq, John F. DiPersio, Sigrid Hatse, Thue W. Schwartz, Simon P. Fricker and Richard T. Maziarz and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Gary Bridger

118 papers receiving 9.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

2005 848 citations Hal E. Broxmeyer, Christie M. Orschell et al. The Journal of Experimental Medicine profile →
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

2009 579 citations John F. DiPersio, Auayporn Nademanee et al. Blood profile →
Chemokines Acting via CXCR2 and CXCR4 Control the Release of Neutrophils from the Bone Marrow and Their Return following Senescence

2003 576 citations Coralie Martin, Gary Bridger et al. Immunity profile →
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

2003 561 citations W. Conrad Liles, Hal E. Broxmeyer et al. Blood profile →
Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

2009 512 citations John F. DiPersio, Ivana N. Micallef et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Gary Bridger

Since Specialization

Citations

This map shows the geographic impact of Gary Bridger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Bridger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Bridger more than expected).

Fields of papers citing papers by Gary Bridger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Bridger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Bridger. The network helps show where Gary Bridger may publish in the future.

Co-authorship network of co-authors of Gary Bridger

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Bridger. A scholar is included among the top collaborators of Gary Bridger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Bridger. Gary Bridger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prospective CCR5 Small Molecule Antagonist Compound Design Using a Combined Mutagenesis/Modeling Approach 2011 ·Journal of the American Chemical Society ·Markus Metz, (unknown), Jean Labrecque, Sanjay Danthi, Jonathan Langille, Curtis Harwig, Wen Yang, Marilyn C. Darkes, Gloria Lau, (unknown), Gary Bridger, Dominique Schols, Simon P. Fricker, Renato T. Skerlj	12
2	Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma breakdown → 2009 ·Journal of Clinical Oncology ·John F. DiPersio, Ivana N. Micallef, Patrick J. Stiff, Brian J. Bolwell, Richard T. Maziarz, Eric D. Jacobsen, Auayporn Nademanee, John M. McCarty, Gary Bridger, Gary Calandra	512
3	Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction 2008 ·Blood ·Steven M. Devine, Ravi Vij, Michael P. Rettig, Laura Todt, (unknown), Nicholas M. Fisher, Hollie Devine, Daniel C. Link, Gary Calandra, Gary Bridger, Peter Westervelt, John F. DiPersio	234
4	Comparison of the Potential Multiple Binding Modes of Bicyclam, Monocylam, and Noncyclam Small-Molecule CXC Chemokine Receptor 4 Inhibitors 2008 ·Molecular Pharmacology ·Rebecca S.Y. Wong, V. Bodart, Markus Metz, Jean Labrecque, Gary Bridger, Simon P. Fricker	106
5	Mobilization as a preparative regimen for hematopoietic stem cell transplantation 2006 ·Blood ·Jing Chen, André Larochelle, Simon P. Fricker, Gary Bridger, Cynthia E. Dunbar, Janis L. Abkowitz	59
6	AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates 2006 ·Blood ·André Larochelle, Allen E. Krouse, Mark E. Metzger, Donald Orlic, Robert E. Donahue, Simon P. Fricker, Gary Bridger, Cynthia E. Dunbar, Peiman Hematti	142
7	The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics 2006 ·Experimental Hematology ·Stefan Früehauf, (unknown), Patrick Maier, Li Li, (unknown), Stephanie Laufs, Wolfgang Wagner, Volker Eckstein, Gary Bridger, Gary Calandra, (unknown), W. Jens Zeller, Hartmut Goldschmidt, Anthony D. Ho	49
8	Multi-drug resistant HIV-1 is sensitive to inhibition by chemokine receptor antagonists 2005 ·Dominique Schols, Kurt Vermeire, Signe Fransen, Wei Huang, Jonathan Toma, Jeannette M. Whitcomb, Christos J. Petropoulos, Gary Calandra, Gary Bridger	3
9	Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist breakdown → 2005 ·The Journal of Experimental Medicine ·Hal E. Broxmeyer, Christie M. Orschell, D. Wade Clapp, Giao Hangoc, Scott Cooper, P. Artur Plett, W. Conrad Liles, Xiaxin Li, Barbara Graham-Evans, Timothy Campbell, Gary Calandra, Gary Bridger, David C. Dale, Edward F. Srour	848
10	A pharmacokinetic-pharmacodynamic model for the mobilization of CD34 hematopoietic progenitor cells by AMD3100 2005 ·Clinical Pharmacology & Therapeutics ·Nathan A. Lack, (unknown), David C. Dale, Gary Calandra, (unknown), R. T. MacFarland, Karin Badel, W. Conrad Liles, Gary Bridger	61
11	Virus resistance to the CXCR4 inhibitor AMD070 develops slowly and does not induce a co-receptor switch 2004 ·Antiviral Research ·Kurt Vermeire, Sigrid Hatse, Katrien Princen, Erik De Clercq, Gary Calandra, Renato T. Skerlj, Gary Bridger, Dominique Schols	2
12	Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 Antagonist 2004 ·PubMed ·Kai Hübel, W. Conrad Liles, Hal E. Broxmeyer, Elin Rodger, Brent L. Wood, Scott Cooper, Giao Hangoc, Ron MacFarland, Gary Bridger, Geoffrey Henson, Gary Calandra, David C. Dale	77
13	Molecular Mechanism of AMD3100 Antagonism in the CXCR4 Receptor 2004 ·Journal of Biological Chemistry ·Mette M. Rosenkilde, Lars‐Ole Gerlach, Janus S. Jakobsen, Renato T. Skerlj, Gary Bridger, Thue W. Schwartz	195
14	In vitro anti-HIV activity profile of AMD887, a novel CCR5 antagonist, in combination with the CXCR4 inhibitor AMD070 2004 ·Dominique Schols, Kurt Vermeire, Sigrid Hatse, Katrien Princen, Erik De Clercq, Gary Calandra, Simon P. Fricker, Kim L. Nelson, (unknown), (unknown), (unknown), Renato T. Skerlj, Gary Bridger	5
15	Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger 2003 ·Journal of Thoracic and Cardiovascular Surgery ·Irvin Mayers, Thomas S. Hurst, Anna Radomski, David H. Johnson, Simon P. Fricker, Gary Bridger, Beth R. Cameron, Marilyn C. Darkes, Marek W. Radomski	19
16	Anti-HIV activity profile of AMD070, an orally bioavailable CXCR4 antagonist 2003 ·Antiviral Research ·Dominique Schols, Sandra Claes, Sigrid Hatse, Katrien Princen, Kurt Vermeire, Erik De Clercq, Renato T. Skerlj, Gary Bridger, Gary Calandra	4
17	The Antiviral Activity of the CXCR4 Antagonist AMD3100 Is Independent of the Cytokine-Induced CXCR4/HIV Coreceptor Expression Level 2003 ·AIDS Research and Human Retroviruses ·Katrien Princen, Sigrid Hatse, Kurt Vermeire, Gary Bridger, Renato T. Skerlj, Erik De Clercq, Dominique Schols	9
18	Chemokines Acting via CXCR2 and CXCR4 Control the Release of Neutrophils from the Bone Marrow and Their Return following Senescence breakdown → 2003 ·Immunity ·Coralie Martin, (unknown), Gary Bridger, Jose‐Carlos Gutierrez‐Ramos, Timothy J. Williams, Sara M. Rankin	576
19	AMD3100, a Potent and Specific Antagonist of the Stromal Cell-Derived Factor-1 Chemokine Receptor CXCR4, Inhibits Autoimmune Joint Inflammation in IFN-γ Receptor-Deficient Mice 2001 ·The Journal of Immunology ·Patrick Matthys, Sigrid Hatse, Kurt Vermeire, Anja Wuyts, Gary Bridger, Geoffrey Henson, Erik De Clercq, Alfons Billiau, Dominique Schols	215
20	Mutation of Asp¹⁷¹and Asp²⁶²of the Chemokine Receptor CXCR4 Impairs Its Coreceptor Function for Human Immunodeficiency Virus-1 Entry and Abrogates the Antagonistic Activity of AMD3100 2001 ·Molecular Pharmacology ·Sigrid Hatse, Katrien Princen, Lars‐Ole Gerlach, Gary Bridger, Geoffrey Henson, Erik De Clercq, Thue W. Schwartz, Dominique Schols	99

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact